The phosphorylation levels of EGFR and its downstream proteins were downregulated in the high GTMEIscore group, suggesting that EGFR activation may inhibit the infiltration of immune cells into tumor tissue and that GBM patients with a high GTMEIscore are insensitive to EGFR inhibitors. This evidence concerns the gene EGFR and neoplasm.